Neuroesquistossomose mansônica: aspectos clínicos, laboratoriais e terapêuticos

Submitted by Ana Maria Fiscina Sampaio ([email protected]) on 2014-05-05T18:28:22Z No. of bitstreams: 1 Andrade Filho AS Neuroesquistossomose Mansonica....pdf: 730449 bytes, checksum: 7a8a49d368d9c1e69c3e7aa5428793a9 (MD5)Made available in DSpace on 2014-05-05T18:28:22Z (GMT). No. of bitstreams: 1 Andrade Filho AS Neuroesquistossomose Mansonica....pdf: 730449 bytes, checksum: 7a8a49d368d9c1e69c3e7aa5428793a9 (MD5) Previous issue date: 1996Hospital Universitário Professor Edgard Santos. Universidade Federal da Bahia. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, BrasilHospital Universitário Professor Edgard Santos. Universidade Federal da Bahia. Salvador, BA, BrasilHospital Universitário Professor Edgard Santos. Universidade Federal da Bahia. Salvador, BA, BrasilHospital Universitário Professor Edgard Santos. Universidade Federal da Bahia. Salvador, BA, BrasilHospital Universitário Professor Edgard Santos. Universidade Federal da Bahia. Salvador, BA, BrasilHospital Universitário Professor Edgard Santos. Universidade Federal da Bahia. Salvador, BA, BrasilHospital Universitário Professor Edgard Santos. Universidade Federal da Bahia. Salvador, BA, BrasilHospital Universitário Professor Edgard Santos. Universidade Federal da Bahia. Salvador, BA, BrasilHospital Universitário Professor Edgard Santos. Universidade Federal da Bahia. Salvador, BA, BrasilHospital Universitário Professor Edgard Santos. Universidade Federal da Bahia. Salvador, BA, BrasilOs autores relatam 16 casos de pacientes com forma meningomielorradicular da neuroesquistossomose mansônica, diagnosticados segundo critérios clínicos, laboratoriais e de imagem, acompanhados no Ambulatório de Neurologia-HUPES-UFBA no período de abril/91 a dezembro/93. Eles foram tratados com praziquantel associado a corticoterapia. O objetivo foi avaliar o grau de eficácia e de segurança da droga na regressão dos sinais e sintomas neurológicos.The authors report 16 patients bearing the meningomyeloradicular form of Mansonic neuroschistosomiasis diagnosed according to clinical, laboratorial and image criteria. Patients have been observed at the Neurology Ambulatory of the Federal University of Bahia, within the period of April/91 to December/93. They have been treated with praziquantel, associated to corticosteroids. The aim has been to evaluate the drug's efficiency and safety in decreasing the neurological signs and symptoms

Alirocumab and cardiovascular outcomes after acute coronary syndrome

BACKGROUN

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

BACKGROUN

Diminishing benefits of urban living for children and adolescents’ growth and development

Optimal growth and development in childhood and adolescence is crucial for lifelong health and well-being1–6. Here we used data from 2,325 population-based studies, with measurements of height and weight from 71 million participants, to report the height and body-mass index (BMI) of children and adolescents aged 5–19 years on the basis of rural and urban place of residence in 200 countries and territories from 1990 to 2020. In 1990, children and adolescents residing in cities were taller than their rural counterparts in all but a few high-income countries. By 2020, the urban height advantage became smaller in most countries, and in many high-income western countries it reversed into a small urban-based disadvantage. The exception was for boys in most countries in sub-Saharan Africa and in some countries in Oceania, south Asia and the region of central Asia, Middle East and north Africa. In these countries, successive cohorts of boys from rural places either did not gain height or possibly became shorter, and hence fell further behind their urban peers. The difference between the age-standardized mean BMI of children in urban and rural areas was <1.1 kg m–2 in the vast majority of countries. Within this small range, BMI increased slightly more in cities than in rural areas, except in south Asia, sub-Saharan Africa and some countries in central and eastern Europe. Our results show that in much of the world, the growth and developmental advantages of living in cities have diminished in the twenty-first century, whereas in much of sub-Saharan Africa they have amplified